Jeffrey A Toretsky
Title
Professor
Molecular Oncology Program Co-leader
Molecular Oncology Program Co-leader
Department
Lombardi Comprehensive Cancer Center (LCCC)
Publications
Publications
Articles in journals
- Toretsky, JA., Brooks, BP., Meck, JM., Haddad, BR., Bendavid, C., & Blain, D. "Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature." BMC Medical Genetics 7.2 (2006).
- Toretsky, J., Kitlinska, J., Kuo, L., Abe, K., Pons, J., Yu, M., Li, L., Tilan, J., & Zukowska, Z. "Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing’s sarcoma growth." Advances in Experimental Medicine and Biology (2006): 223-9.
- Toretsky, JA., Erkizan, V., Levenson, A., Abaan, OD., Parvin, JD., Cripe, TP., Rice, AM., Lee, SB., & Uren, A. "Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A." Cancer Research 66.11 (2006): 5574-81.
- Toretsky, JA., & Uren, A. "Ewing’s sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent." Future Oncology 1.4 (2005): 521-8.
- Toretsky, JA., Uren, A., Fallen, S., Yuan, H., Usubutun, A., Kucukali, T., & Schlegel, R. "Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression." Cancer Research 65.14 (2005): 6199-206.
- Toretsky, JA., Abaan, OD., Levenson, A., Khan, O., Furth, PA., & Uren, A. "PTPL1 is a direct transcriptional target of EWS-FL1 and modulates Ewing’s Sarcoma tumorigenesis." Oncogene 24.16 (2005): 2715-22.
- Toretsky, JA., Kitlinska, J., Abe, K., Kuo, L., Pons, J., Yu, M., Li, L., Tilan, J., Everhart, L., Lee, EW., & Zukowska, Z. "Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors." Cancer Research 65.5 (2005): 1719-28.
- Toretsky, JA., & Uren, A. "Pediatric malignancies provide unique cancer therapy targets." Current Opinion in Pediatrics 17.1 (2005): 14-9.

